Guidance

Benefit-risk report (BRR) and signal notification submissions

OnceBenefit-Risk aSubmission VMPReport is(BRSR) onand thePharmacovigilance UKSales marketSubmission an(PSS) MAHtemplates must record and submitguidance thefor resultscompletion of theirBRSRs, signalPSSs management process, alongside sales and worldwidesignal authorisation status data.notifications.

From:
Veterinary Medicines Directorate
Published
20 May 2024
Last updated
22 August 2024 — See all updates

Documents

NewBenefit-Risk VMRSubmission BenefitReport - risk report(BRSR)

Ref: 2831835

ODS, 9.969.3 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email postmaster@vmd.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Following

Technical theguidance placingfor completion of athe VMPBenefit-Risk onSubmission theReport market(BRSR)

Ref: in2828075

PDF, the532 UK,KB, 21 pages

This file may not be suitable for users of assistive technology.

Request an MAHaccessible mustformat.
If recordyou use assistive technology (such as a screen reader) and submitneed thea resultsversion of theirthis signaldocument managementin process,a alongsidemore salesaccessible andformat, worldwideplease authorisationemail statuspostmaster@vmd.gov.uk. data.Please Thistell mustus bewhat sentformat toyou theneed. VMDIt viawill thehelp Benefit-riskus reportif andyou Signalsay notificationwhat template.

assistive technology you use.

The

Technical Benefit-riskguidance reportfor includingcompletion salesof dataStandard and worldwideUrgent authorisationSignal statusNotifications

Ref: information2839832

PDF, should367 eitherKB, 13 pages

This file may not be submittedsuitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as onea completescreen reader) and need a version of this document annuallyin ora canmore beaccessible splitformat, intoplease multipleemail submissions.

postmaster@vmd.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

If

Pharmacoviligance multipleSales submissionsSubmission are(PSS)

Ref: made2831834

ODS, at3.73 differentKB

This timepoints,file oneis mustin containan atOpenDocument aformat

This minimumfile themay benefit-risknot statementbe andsuitable validatedfor signalsusers whichof areassistive deemed:technology.

  • not Request toan suggestaccessible format.
    If you use assistive technology (such as a newscreen risk
  • changereader) toand theneed benefit-riska balance,version or
  • requireof furtherthis investigation,document ifin anya havemore beenaccessible detectedformat, duringplease theemail reportingpostmaster@vmd.gov.uk. period
    • Please tell us what format you need. It will help us if you say what assistive technology you use.